PTHS vs MSFT: Which Stock is Better?
Side-by-side comparison of Pelthos Therapeutics Inc. and Microsoft Corporation in 2026
PTHS
Pelthos Therapeutics Inc.
$24.82
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | PTHS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $94.75M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze PTHS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PTHS or MSFT a better investment?
Comparing PTHS and MSFT: Pelthos Therapeutics Inc. has a market cap of $94.75M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PTHS and MSFT?
PTHS (Pelthos Therapeutics Inc.) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PTHS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PTHS or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for PTHS.
Which company is more profitable: PTHS or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for PTHS.
Which is the larger company: PTHS or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $94.75M for PTHS.
Should I buy PTHS or MSFT in 2026?
Both PTHS and MSFT have investment merit. PTHS trades at $24.82 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PTHS and MSFT stock?
Key differences: Market Cap ($94.75M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy PTHS or MSFT in 2026?
The choice between PTHS and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PTHS and MSFT?
PTHS (Pelthos Therapeutics Inc.) has a market cap of $94.75M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.